Qiushui Xianjian Pian (秋水仙碱片)秋水仙碱片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

秋水仙碱是一种在国家药监局注册认定的药品。该药品含有为一种生物碱、四氢、秋水仙碱-05cf4fdb等成分。

该药品关联的活性成分包括:为一种生物碱Recorded Chinese composition: 为一种生物碱、四氢Si Qing、秋水仙碱Qiushui Xianjian。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:通化利民药业有限责任公司Chinese legal name: 通化利民药业有限责任公司。

您可以探索含有相同成分的其他药品:为一种生物碱-c1955ce2成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 秋水仙碱片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 为一种生物碱Recorded Chinese composition: Recorded Chinese name: 为一种生物碱, 四氢Si Qing, 秋水仙碱Qiushui Xianjian.

Manufacturers recorded for this product: 通化利民药业有限责任公司Chinese legal name: 通化利民药业有限责任公司.

Explore other medicines containing the same ingredient: 为一种生物碱 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 秋水仙碱片Recorded Chinese name: 秋水仙碱片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 0.5mg0.5 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 通化利民药业有限责任公司Chinese legal name: 通化利民药业有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H22022643

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H22022643

Manufacturer

Chinese legal name: 通化利民药业有限责任公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H22022643

生产企业

通化利民药业有限责任公司(国产)

适应症

本品治疗痛风性关节炎的急性发作、预防复发性痛风性关节炎的急性发作。

用法用量

口服给药。 1.急性期:成人常用量为每1~2小时服0.5~1mg?直至关节症状缓解、或出现腹泻或呕吐,达到治疗量一般为3~5mg,24小时内不宜超过6mg,停服72小时后一日量为0.5~1.5mg,分次服用,共7天。 2.预防:一日0.5~1.0mg,分次服用,但疗程酌定,如出现不良反应应随时停药。

不良反应

与剂量大小有明显相关性,口服较静脉注射安全性高。1. 胃肠道症状、腹痛,腹泻,呕吐及食欲不振为常见的早期不良反应,发生率可达80%,严重者可造成脱水及电解质紊乱等表现。长期服用者可出现严重的出血性胃肠炎或吸收不良综合症。2. 肌肉,周围神经病变、有近端肌无力和(或)血清肌酸磷酸激酶增高。在肌细胞受损同时可出现周围神经轴突性多神经病变,表现为麻木,刺痛和无力。肌神经病变并不多见,往往在预防痛风而长期服用者和有轻度肾功能不全者出现。3. 骨髓抑制、出现血小板减少,中性细胞下降,甚至再生障碍性贫血,有时可危及生命。4. 休克、表现为少尿,血尿,抽搐及意识障碍。死亡率高,多见于老年人。5. 致畸、文献报道两例Down综合征婴儿的父亲均为因家族性地中海热而有长期服用秋水仙碱史者。6. 其他、脱发,皮疹,发热及肝损害等。

禁忌

对骨髓增生低下、及肾和肝功能不全者禁用。

注意事项

1. 如发生呕吐、腹泻等反应,应减小用量,严重者应立即停药。
2. 骨髓造血功能不全,严重心脏病、肾功能不全及胃肠道疾患者慎用。
3. 用药期间应定期检查血象及肝、肾功能。
4. 另女性患者在服药期间及停药以后数周内不得妊娠。

贮藏

密闭。

规格

0.5mg

证据Evidence

  • 批准文号: 国药准字H22022643
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.